- Disease: Acute COVID-19
- Study type: Observational Cohort Study, Treatment
- Study type descriptors: Prospective, Single centre
- Objective: To investigate the potential prognostic role of neutrophil and lymphocyte count regarding tocilizumab treatment in patients with severe COVID-19 pneumonia and high concentration of IL-6
- Number of participants enrolled: 31
- Study enrolling from to
- Study includes follow-up for 1 month
Study Data
- Adults (18-64 years)
- Elderly (≥65 years)
- Hospital
- SARS-CoV-2
- Acute COVID-19
- Pharmacological intervention
- Monoclonal antibodies
- Tocilizumab
External Links
Other information
The information was provided with the aid of the study investigators
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to